Features of COVID-19 post-infectious cytokine release syndrome in children presenting to the emergency department

T Waltuch, P Gill, LE Zinns, R Whitney… - The American Journal of …, 2020 - Elsevier
Abstract The 2019 coronavirus disease (COVID-19) has not appeared to affect children as
severely as adults. However, approximately 1 month after the COVID-19 peak in New York …

Current understanding of multisystem inflammatory syndrome (MIS-C) following COVID-19 and its distinction from Kawasaki disease

H Bukulmez - Current rheumatology reports, 2021 - Springer
Abstract Purpose of Review In this article, I have reviewed current reports that explore
differences and similarities between multisystem inflammatory syndrome in children (MIS-C) …

Distinguishing between typical Kawasaki disease and multisystem inflammatory syndrome in children (MIS-C) associated with SARS-CoV-2

WS Yeo, QX Ng - Medical hypotheses, 2020 - Elsevier
In recent months, there are increasing reports of a Kawasaki disease-like syndrome in
children infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

Advances in the research of cytokine storm mechanism induced by Corona Virus Disease 2019 and the corresponding immunotherapies

C Chen, X ZHANG, Z JU, W HE - Chinese journal of burns, 2020 - pesquisa.bvsalud.org
ABSTRACT Corona Virus Disease 2019 (COVID-19) has seriously affected the treatment of
patients and social stability. In the later stage of disease, some COVID-19 patients may …

Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management

J Kabeerdoss, RK Pilania, R Karkhele… - Rheumatology …, 2021 - Springer
Multisystem inflammatory syndrome (MIS-C) is a pediatric hyperinflammation disorder
caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). It has now been …

Multisystem inflammatory syndrome in children related to COVID‐19: A New York City experience

M Riollano‐Cruz, E Akkoyun… - Journal of Medical …, 2021 - Wiley Online Library
Abstract In December 2019, the 2019, a novel coronavirus disease (COVID‐19) caused by
severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) first emerged in Wuhan …

Cytokine release syndrome (CRS) and nicotine in COVID-19 patients: trying to calm the storm

J Gonzalez-Rubio, C Navarro-Lopez… - Frontiers in …, 2020 - frontiersin.org
SARS-CoV-2 is a new coronavirus that has caused a worldwide pandemic. It causes severe
acute respiratory syndrome (COVID-19), which is fatal in many cases, and is characterized …

Multisystem inflammatory syndrome in children (MIS-C)

JM Patel - Current allergy and asthma reports, 2022 - Springer
Abstract Purpose of Review The novel coronavirus disease 2019 (COVID-19) is caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has developed into a …

COVID-19 and cytokine storm syndrome: are there lessons from macrophage activation syndrome?

MJ Ombrello, GS Schulert - Translational Research, 2021 - Elsevier
Although interest in “cytokine storms” has surged over the past decade, it was massively
amplified in 2020 when it was suggested that a subset of patients with COVID-19 developed …

Understanding SARS-CoV-2-related multisystem inflammatory syndrome in children

AH Rowley - Nature Reviews Immunology, 2020 - nature.com
A new multisystem inflammatory syndrome apparently related to infection with SARS-CoV-2
has recently been reported in older children (known as MIS-C), manifested by severe …